Researcher Spotlight Home » Andrew Jallouk, MD, PhD Researcher Spotlight: Andrew Jallouk, MD, PhD VANDERBILT UNIVERSITY MEDICAL CENTER Errol M. Cook Memorial Scholar Chimeric antigen receptor (CAR) T-cell therapy represents a highly effective treatment option for many types of lymphoma. Currently available CAR T-cell therapies are...
Researcher Spotlight Home » Alexander Boardman, MD Researcher Spotlight: Alexander Boardman, MD MEMORIAL SLOAN KETTERING Dobosh Family Scholar Treatment of lymphoma has been revolutionized by the emergence of CD19-directed chimeric antigen receptor (CAR) T-cell therapies, but many patients still relapse after treatment. Dr. Boardman’s LRF research...
Researcher Spotlight Home » Christine Ryan, MD Researcher Spotlight: Christine Ryan, MD DANA-FARBER CANCER INSTITUTE Kanti R. Rai, MD Clinical Scholar Richter’s transformation (RT) represents a devastating progression of chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL) into an aggressive B-cell lymphoma. Prognosis with...
What to Expect After Submitting Your Fellowship Application: Tips for Hematology-Oncology Fellowship Application From Current Fellows
By Karun Neupane, MD, Fionnuala Crowley, MD, Franco Castillo Tokumori, MD, Kristine Lacuna, MD, Alma Habib, MD, Muhammad Salman Faisal, MD, Andrea Anampa-Guzmán, MD, and Aakash Desai, MD, MPHHemOncFellows Network (@HemOncFellows) organized a Twitter Spaces session on August 4, 2023, to address the common questions that hematology-oncology fellowship applicants have after submitting their fellowship...
It was such a great pleasure and satisfaction to organize and hold the 18th Annual Best of ASCO (BOA) Lebanon Meeting on July 7-8, 2023, at the American University of Beirut Medical Center (AUBMC) in a hybrid format from the Daniel ACC Building Ground Floor Conference Rooms. Speakers and attendees in Lebanon were present...
Finding My Community: Building a Strong Network to Improve Sarcoma Care and AYA Oncology in the Philippines
By Paula Isabel G. Franco, MDEver since I started my oncology training in the Philippines, the dream was to become a recipient of the International Development and Education Award (IDEA) grant from ASCO and Conquer Cancer, the ASCO Foundation. Each year, IDEA enables early-career oncologists, surgeons, and palliative care specialists to attend the ASCO...
Everything You Need to Know About Hematology-Oncology Fellowship Applications: Tips From Current and Incoming Fellows
By Karun Neupane, MD, Muhammad Salman Faisal, MD, Zunairah Shah, MD, Mercy C. Anyanwu, MD, Sushmita Khadka, MD, Laercio DaSilva, MD, Pamela Contreras-Chavez, MD, Andrea Anampa-Guzmán, MD, and Aakash Desai, MD, MPHTo address the common questions that fellowship applicants have, especially those applying for a hematology-oncology fellowship, HemOncFellows Network (@HemOncFellows) organized a Twitter Spaces session...
Researcher Spotlight Home » Wendy Béguelin, PhD Researcher Spotlight: Wendy Béguelin, PhD WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY Follicular lymphoma (FL) is a clinically heterogenous disease. For some patients, tumors are slow growing and outcomes are favorable; others experience a high-risk, rapidly progressing disease that...
Researcher Spotlight Home » Matthew Maurer, D.M.Sc Researcher Spotlight: Matthew Maurer, D.M.Sc MAYO CLINIC, ROCHESTER Follicular lymphoma (FL) is a heterogeneous disease characterized by episodes of relapse and transformation. Prognostic models exist that can be applied at diagnosis to predict how the disease will progress...
The Australasian Teletrial Model: A National Approach to Decentralizing Clinical Trials Into Regional and Rural Communities
By Sabe Sabesan, PhD, FRACPGrowing up in a village in Northern Sri Lanka, befriending rural Australians in medical school at Flinders University in Adelaide, and doing my internship in Alice Springs provided me lived and observed experience of the enduring daily difficulties in accessing health services faced by regional and rural communities. Negative experiences...
Time Management Tips
29.8 ° C